SERVICES

Archive | Drugs and Pharmaceuticals

(c) Send2Press

Epeius Biotechnologies Reaches Out to American Cancer Patients, Gains FDA Approval for Two New Clinical Trials Using Rexin-G(TM) for Breast Cancer and Sarcoma

SAN MARINO, Calif. – June 4 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today the expansion of ongoing clinical trials using Rexin-G(TM) in the United States to include breast cancer and all types of sarcomas that have failed standard chemotherapy. Following on the heels of their landmark clinical trials in the United States and abroad, […]

Continue Reading
(c) Send2Press

Drug Development Costs Exceed $802 Million: Global Pharmas Use Clintelligence to Do Something About It

KENILWORTH, N.J. – May 2, 2007 (SEND2PRESS NEWSWIRE) — 3C Company, Inc., a leading provider of Business Performance Optimization (BPO) solutions to the Life Sciences Industry, announced today that it has aligned with yet another Global Pharmaceutical Firm to implement Clintelligence – 3C Company’s Business Intelligence Solution for strategic and tactical oversight of their Research […]

Continue Reading
(c) Send2Press

Tired… Distressed… Unhappy? All Natural ‘Feel Good’ Pill Strikes a Chord with Millions of Women

SALT LAKE CITY, Utah – Apr. 26 (SEND2PRESS NEWSWIRE) — This provocative opening line from a television commercial for a ‘mood elevating’ pill has really struck a nerve. If the overwhelming response to the Libutol(TM) ad is any indication, it seems American women are more tired, distressed and unhappy than most experts (and women themselves) […]

Continue Reading

	 SAN MARINO, CA - Apr. 7 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation announced today that the Philippine Bureau of Food and Drugs (BFAD) has approved an Expanded Access Program for Rexin-G(TM), the lead product of Epeius Biotechnologies, developed for the treatment of metastatic cancer. Following the landmark approval of Rexin-G(TM) for the treatment of all solid tumors, the Expanded Access Program extends the clinical applications of the world's first targeted genetic medicine to many more cancer patients and enables Epeius Biotechnologies to recoup some of the costs of its ongoing clinical trials in Manila.

Expanded Access Program for Rexin-G Provides Genetic Medicine to Cancer Patients, First Revenues for Epeius Biotechnologies

SAN MARINO, CA – Apr. 7 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today that the Philippine Bureau of Food and Drugs (BFAD) has approved an Expanded Access Program for Rexin-G(TM), the lead product of Epeius Biotechnologies, developed for the treatment of metastatic cancer. Following the landmark approval of Rexin-G(TM) for the treatment of all […]

Continue Reading

	 SANTA BARBARA, Calif. -- (SEND2PRESS NEWSWIRE) -- The nation's top hospital infection fighters will be getting a look at a new breakthrough ergonomic hand sanitizer that holds the promise of preventing 20,000 to 50,000 U.S. deaths each year. Sprixx is an alcohol hand sanitizer dispenser that you wear, use on-the-go, and is ergonomically designed to become a second-nature habit in use.

Breakthrough New Ergonomic Hand Sanitizer to be Introduced to Nation’s Top Hospital Infection Fighters

SANTA BARBARA, Calif. — (SEND2PRESS NEWSWIRE) — The nation’s top hospital infection fighters will be getting a look at a new breakthrough ergonomic hand sanitizer that holds the promise of preventing 20,000 to 50,000 U.S. deaths each year. Sprixx is an alcohol hand sanitizer dispenser that you wear, use on-the-go, and is ergonomically designed to […]

Continue Reading

Rexin-G, the World’s First Tumor-Targeted Gene Delivery Vector Used in Phase I Clinical Trial

LOS ANGELES, Calif. — (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corp. announced today that a Phase I clinical trial has opened in New York to test the safety and efficacy of Rexin-G, the leading tumor-targeted gene delivery system (vector) developed for the treatment of metastatic colon and pancreatic cancer.

Continue Reading

Novel Patented Technology Enables Low Cost, Instant Ultraviolet Disinfection for Home and Personal Care Products

BOSTON, MA /Send2Press Newswire/ — Ultraviolet disinfection technology developed for hospital-use now available for a number of home and personal care products such as toothbrushes, pacifiers, drinking cups, knives, cutting boards, etc. reports UVSolutions, LLC (www.uvs-ultraclean.com).

Continue Reading

Part of the Neotrope® News Network, USA. Neotrope.net